Results 201 to 210 of about 84,160 (241)
Some of the next articles are maybe not open access.

CB2 cannabinoid receptor mediation of antinociception

Acute Pain, 2006
Management of acute pain remains a significant clinical problem. In preclinical studies, CB2 cannabinoid receptor-selective agonists inhibit nociception without producing central nervous system side effects. The CB2 receptor-selective agonist AM1241 produces antinociceptive effects that are antagonized by CB2, but not CB1, receptor-selective ...
Mohab M, Ibrahim   +9 more
openaire   +2 more sources

The Search for Selective Ligands for the CB2 Receptor

Current Pharmaceutical Design, 2000
Following the identification of the CB2 receptor several groups explored the development of selective ligands for this receptor which occurs principally in the periphery. This led to the discovery that two cannabimimetic indoles, 1-(2, 3-dichlorobenzoyl)-2-methyl-3-(2-[1-morpholino]ethyl)-5-methoxyind ole (L768242) and 2-methyl-1-propyl-3-(1-naphthoyl ...
openaire   +2 more sources

Morpholine containing CB2 selective agonists

Bioorganic & Medicinal Chemistry Letters, 2009
Identification and optimization of two classes of CB2 selective agonists are described. A representative from each class is profiled in a murine model of inflammation and each shows similar efficacy to prednisolone upon oral dosing.
Renée, Zindell   +10 more
openaire   +2 more sources

Pharmacology of cannabinoid CB1 and CB2 receptors

Pharmacology & Therapeutics, 1997
There are at least two types of cannabinoid receptors, CB1 and CB2, both coupled to G-proteins. CB1 receptors are present in the central nervous system and CB1 and CB2 receptors in certain peripheral tissues. The existence of endogenous cannabinoid receptor agonists has also been demonstrated.
openaire   +2 more sources

Virtual Screening of Novel CB2 Ligands Using a Comparative Model of the Human Cannabinoid CB2 Receptor

Journal of Medicinal Chemistry, 2005
To identify novel selective CB2 lead compounds, a comparative model of the CB2 receptor was constructed using the high-resolution bovine rhodopsin X-ray structure as a template. The CB2 model was utilized both in building the database queries and in filtering the hit compounds by a docking and scoring method.
Outi M H, Salo   +7 more
openaire   +2 more sources

Activation of CB2 Receptors by (−)-Cannabichromene but Not (+)-Cannabichromene

Cannabis & Cannabinoid Research
Introduction: Cannabichromene (CBC) is a minor constituent of cannabis that is a selective cannabinoid CB2 receptor agonist and activator of TRPA1. To date, it has not been shown whether (−)-CBC, (+)-CBC, or both can mediate these effects.
Michael Udoh   +6 more
openaire   +2 more sources

Developing the Cannabinoid Receptor 2 (CB2) Pharmacopoeia: Past, Present, and Future

Trends in Pharmacological Sciences, 2022
Andrea J. Vernall   +2 more
exaly  

Cannabinoid CB2 receptor (CNR2; CB2)

Science-Business eXchange, 2009
openaire   +1 more source

Agonist-Inverse Agonist Characterization at CB1 and CB2 Cannabinoid Receptors of L759633, L759656 and AM630

British Journal of Pharmacology, 1999
Ruth A Ross   +2 more
exaly  

Home - About - Disclaimer - Privacy